Abstract

Major depressive disorder (MDD) is a devastating and heterogenous disorder for which there are no approved biomarkers in clinical practice. We recently identified anticipatory hypo-arousal indexed by pupil responses as a candidate mechanism subserving depression symptomatology. Here, we conducted a replication and extension study of these findings. We analyzed a replication sample of 40 unmedicated patients with a diagnosis of depression and 30 healthy control participants, who performed a reward anticipation task while pupil responses were measured. Using a Bayesian modelling approach taking measurement uncertainty into account, we could show that the negative correlation between pupil dilation and symptom load during reward anticipation is replicable within MDD patients, albeit with a lower effect size. Furthermore, with the combined sample of 136 participants (81 unmedicated depressed and 55 healthy control participants), we further showed that reduced pupil dilation in anticipation of reward is inversely associated with anhedonia items of the Beck Depression Inventory in particular. Moreover, using simultaneous fMRI, particularly the right anterior insula as part of the salience network was negatively correlated with depressive symptom load in general and anhedonia items specifically. The present study supports the utility of pupillometry in assessing noradrenergically mediated hypo-arousal during reward anticipation in MDD, a physiological process that appears to subserve anhedonia.

Details

Title
Assessing hypo-arousal during reward anticipation with pupillometry in patients with major depressive disorder: replication and correlations with anhedonia
Author
Brendler, Andy 1 ; Schneider, Max 1 ; Elbau, Immanuel G. 2 ; Sun, Rui 3 ; Nantawisarakul, Taechawidd 1 ; Pöhlchen, Dorothee 1 ; Brückl, Tanja 1 ; Brem, A. K. 4 ; Binder, E. B. 5 ; Erhardt, A. 5 ; Fietz, J. 1 ; Grandi, N. C. 5 ; Kim, Y. 6 ; Ilić-Ćoćić, S. 6 ; Leuchs, L. 6 ; Lucae, S. 6 ; Namendorf, T. 6 ; Pape, J. 6 ; Schilbach, L. 7 ; von Mücke-Heim, I. 5 ; Ziebula, J. 6 ; Czisch, Michael 6 ; Sämann, Philipp G. 6 ; Lee, Michael D. 8 ; Spoormaker, Victor I. 1 

 Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095) 
 Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Weill Cornell Medical College, Department of Psychiatry, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Zhejiang University, Department of Psychology and Behavioral Sciences, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 University Hospital of Old Age Psychiatry, University of Bern, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157) 
 Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095) 
 Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095) 
 LVR-Klinikum Düsseldorf, Department of General Psychiatry 2, Düsseldorf, Germany (GRID:grid.419548.5) 
 University of California, Department of Cognitive Sciences, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243) 
Pages
344
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2909358385
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.